Traina, T. A., Chen, Y., Abdou, Y., Jahan, N., Mayer, E. L., Melisko, M. E., Syldor, A., Camacho, L., Savoie, J., Pareja, F., Weigelt, B., Chandarlapaty, S., Turner, N. C., Sharifi, M. N., Conzen, S. D., Nanda, R. (2026). TBCRC 058: A randomized phase II study of enzalutamide, enzalutamide with mifepristone, and treatment of physician’s choice in patients with androgen receptor-positive metastatic triple-negative or estrogen receptor-low breast cancer (NCT06099769).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.tps1162